Full Text View
Tabular View
No Study Results Posted
Related Studies
Ketamine on Acute Pain in Females and Males
This study has been completed.
Study NCT00232492   Information provided by Oslo University Hospital

First Received on September 30, 2005.   Last Updated on July 3, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Mouth and Tooth Diseases
Tooth, Impacted
Additional conditions recognized in this trial
Stomatognathic Diseases
Tooth Diseases
Interventions listed in this trial
Placebo males
Ketamine 0,1 mg/kg males
Ketamine 0,3 mg/kg males
Ketamine 0,5 mg/kg males
Placebo females
Ketamine 0,1 mg/kg females
Ketamine 0,3 mg/kg females
Ketamine 0,5 mg/kg females
Additional drug interventions recognized in this trial
Ketamine
More general drug interventions related to this trial
Analgesics
Anesthetics
Anesthetics, Dissociative
Anesthetics, General
Anesthetics, Intravenous
Central Nervous System Agents
Central Nervous System Depressants
Excitatory Amino Acid Agents
Excitatory Amino Acid Antagonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Ullevaal University Hospital
Section of dental Pharmacology and Pharmacotherapy, University of Oslo, Norway


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services